A 6-Month, Open-Label, Safety Trial Of Pregabalin In Adolescent Patients With Fibromyalgia
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Pfizer
- 30 Jun 2016 Time frame changed from 6 month to Baseline, Weeks 3, 8, 16, 24 and Last Visit.
- 01 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Nov 2014 Planned End Date changed from 1 Nov 2014 to 1 Jun 2015, according to ClinicalTrials.gov record